These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 11748579)

  • 41. Aspiration cytology of chromophobe cell carcinoma of the kidney.
    Akhtar M; Ali MA
    Diagn Cytopathol; 1995 Nov; 13(4):287-94. PubMed ID: 8599910
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluorescence in situ hybridization as an adjunct tool in the diagnosis of primary and metastatic renal cell carcinoma in fine needle aspiration specimens.
    Kos Z; Williams PA; Belanger EC; Mai KT
    Diagn Cytopathol; 2014 Dec; 42(12):1013-23. PubMed ID: 24692327
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Chromophobe renal cell carcinoma: a clinicopathologic study and immunophenotypes of 42 cases].
    Zhang W; Yu WJ; Jiang YX; Li YJ; Han F; Liu Y; Han ZL
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):76-80. PubMed ID: 22455881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinicopathological features of low-grade oncocytic renal tumor (CD117-negative, cytokeratin 7-positive): report of seven cases].
    Xie B; Cheng LC; Yin GL; Liu BA; Hu ZL; Tong K
    Zhonghua Bing Li Xue Za Zhi; 2022 Aug; 51(8):719-725. PubMed ID: 35922161
    [No Abstract]   [Full Text] [Related]  

  • 45. Chromophobe renal cell carcinoma: a morphologic and immunohistochemical study of 45 cases.
    Din NU; Fatima S; Ahmad Z
    Ann Diagn Pathol; 2013 Dec; 17(6):508-13. PubMed ID: 24095630
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Typing of renal tumors by morphological and immunocytochemical evaluation of fine needle aspirates.
    Strojan Fležar M; Gutnik H; Jeruc J; Kirbiš IS
    Virchows Arch; 2011 Dec; 459(6):607-14. PubMed ID: 22052200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinicopathological features of hybrid oncocytic/chromophobe renal cell tumor].
    Wang Y; Chong DC; Xin FJ; He B; Liu XL; Li YJ; Zhang W; Jiang YX
    Zhonghua Bing Li Xue Za Zhi; 2021 Feb; 50(2):97-102. PubMed ID: 33535302
    [No Abstract]   [Full Text] [Related]  

  • 48. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Review of chromophobe renal cell carcinoma with focus on clinical and pathobiological aspects.
    Kuroda N; Toi M; Hiroi M; Enzan H
    Histol Histopathol; 2003 Jan; 18(1):165-71. PubMed ID: 12507296
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Renal oncocytoma with and without intravascular extension into the branches of renal vein have the same morphological, immunohistochemical and genetic features.
    Hes O; Michal M; Síma R; Vanecek T; Brunelli M; Martignoni G; Kuroda N; Cabrero IA; Perez-Montiel D; Hora M; Urge T; Dvorák M; Jarosová M; Yang X
    Virchows Arch; 2008 Mar; 452(3):285-93. PubMed ID: 18196270
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms.
    Avery AK; Beckstead J; Renshaw AA; Corless CL
    Am J Surg Pathol; 2000 Feb; 24(2):203-10. PubMed ID: 10680888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
    Pan CC; Chen PC; Ho DM
    Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
    Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
    AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma.
    Adley BP; Gupta A; Lin F; Luan C; Teh BT; Yang XJ
    Am J Clin Pathol; 2006 Jul; 126(1):79-85. PubMed ID: 16753598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Imprint cytologic features of chromophobe renal cell carcinoma morphologically resembling renal oncocytoma: is this an oncocytic variant of chromophobe renal cell carcinoma?
    Yamaguchi T; Kuroda N; Imamura Y; Hes O; Michal M; Sima R; Nakayama K; Sato N
    Diagn Cytopathol; 2010 Jul; 38(7):509-13. PubMed ID: 19941365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Renal cell tumors with an entrapped papillary component: a collision with predilection for oncocytic tumors.
    Williamson SR; Cheng L; Gadde R; Giannico GA; Wasco MJ; Taylor Smith PJ; Gupta NS; Grignon DJ; Jorda M; Kryvenko ON
    Virchows Arch; 2020 Mar; 476(3):399-407. PubMed ID: 31444626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors.
    Skinnider BF; Folpe AL; Hennigar RA; Lim SD; Cohen C; Tamboli P; Young A; de Peralta-Venturina M; Amin MB
    Am J Surg Pathol; 2005 Jun; 29(6):747-54. PubMed ID: 15897741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Role of CK7, S100A1, and CD82 (KAI1) Expression in the Differential Diagnosis of Chromophobe Renal Cell Carcinoma and Renal Oncocytoma.
    Sari ZB; Açikalin MF; Arik D; Özen A; Can C; Çolak E
    Appl Immunohistochem Mol Morphol; 2021 Aug; 29(7):534-540. PubMed ID: 33605572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An In-vivo Prospective Study of the Diagnostic Yield and Accuracy of Optical Biopsy Compared with Conventional Renal Mass Biopsy for the Diagnosis of Renal Cell Carcinoma: The Interim Analysis.
    Buijs M; Wagstaff PGK; de Bruin DM; Zondervan PJ; Savci-Heijink CD; van Delden OM; van Leeuwen TG; van Moorselaar RJA; de la Rosette JJMCH; Laguna Pes MP
    Eur Urol Focus; 2018 Dec; 4(6):978-985. PubMed ID: 29079496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma.
    Mazal PR; Exner M; Haitel A; Krieger S; Thomson RB; Aronson PS; Susani M
    Hum Pathol; 2005 Jan; 36(1):22-8. PubMed ID: 15712178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.